Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclax
Alexandra Niedermayer(Universität Ulm), Klaus‐Michael Debatin(University Hospital Ulm)
Cited by 4
Related Papers
CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling
|The Journal of Experimental Medicine|2009|47
Transitory dasatinib-resistant states in KITmut t(8;21) acute myeloid leukemia cells correlate with altered KIT expression
|Experimental Hematology|2013|12